ORIC Pharmaceuticals, Inc. (ORIC)
USD 7.68
(-6.91%)
USD 7.68
(-6.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -85.91 Million | -75.14 Million | -59.54 Million | -45.26 Million | -23.53 Million | -20.68 Million |
| Net Income | -100.69 Million | -89.12 Million | -78.71 Million | -73.7 Million | -26.88 Million | -21.36 Million |
| Depreciation & Amortization | 1.03 Million | 966 Thousand | 897 Thousand | 970 Thousand | 1.02 Million | 903 Thousand |
| Deferred income taxes | -3.27 Million | - | - | 299 Thousand | - | - |
| Stock-based compensation | 15.22 Million | 14.46 Million | 12.85 Million | 5.27 Million | 1.09 Million | 469 Thousand |
| Change in working capital | 4.89 Million | -445 Thousand | 4.07 Million | 2.04 Million | 1.22 Million | -707 Thousand |
| Other non-cash items | -3.09 Million | -1 Million | 1.35 Million | 19.84 Million | 8000.00 | 15 Thousand |
| Investing Cash Flow | -43.4 Million | -109.24 Million | 158.43 Million | -215.95 Million | -768 Thousand | -508 Thousand |
| Investments in PPE | -849 Thousand | -2.07 Million | -939 Thousand | -667 Thousand | -768 Thousand | -525 Thousand |
| Acquisitions | 849 Thousand | 2.07 Million | 1.37 Million | - | - | - |
| Investment purchases | -239.24 Million | -238.12 Million | -69.62 Million | -225.48 Million | - | - |
| Sales/Maturities of investments | 196.69 Million | 130.95 Million | 229 Million | 10 Million | - | - |
| Other Investing Activities | -849 Thousand | -2.07 Million | -1.37 Million | 193 Thousand | - | 17 Thousand |
| Financing Cash Flow | 85.88 Million | 25.62 Million | 49.13 Million | 250.51 Million | 70.82 Million | 38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 545 Thousand | - | - | - | - |
| Common Stock Issuance | 85.88 Million | 25.62 Million | 50 Million | 271.3 Million | 70.92 Million | 38 Million |
| Other Financing Activities | -227 Thousand | -399 Thousand | -866 Thousand | -20.79 Million | -99 Thousand | 38 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.27 Million | -1.47 Million | 2.93 Million | 4.3 Million | 986 Thousand | -410 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.62 Million | 1.03 Million | 1.14 Million | -2.25 Million | 234 Thousand | -297 Thousand |
| Cash at beginning of period | 66.84 Million | 226.47 Million | 78.44 Million | 89.15 Million | 42.63 Million | 25.81 Million |
| Cash at end of period | 23.38 Million | 67.3 Million | 226.47 Million | 78.44 Million | 89.15 Million | 42.63 Million |
| Capital Expenditure | -849 Thousand | -2.07 Million | -939 Thousand | -667 Thousand | -768 Thousand | -525 Thousand |
| Effect of forex changes on cash | -23 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -43.45 Million | -159.16 Million | 148.02 Million | -10.71 Million | 46.52 Million | 16.81 Million |
| Free Cash Flow | -86.76 Million | -77.22 Million | -60.48 Million | -45.93 Million | -24.3 Million | -21.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.96 Million | -25.01 Million | -28.33 Million | -100.69 Million | -25.47 Million | -22.94 Million |
| Depreciation & Amortization | 272 Thousand | 261 Thousand | 263 Thousand | 1.03 Million | 257 Thousand | 259 Thousand |
| Deferred income taxes | - | - | -3.47 Million | -3.27 Million | - | - |
| Stock-based compensation | 4.99 Million | 4.95 Million | 3.92 Million | 15.22 Million | 3.86 Million | 3.82 Million |
| Change in working capital | 3.36 Million | -8.16 Million | 1.98 Million | 4.89 Million | 3.63 Million | -1.03 Million |
| Other non-cash items | -556 Thousand | 8.84 Million | 1.13 Million | -3.09 Million | -1.92 Million | -1.25 Million |
| Investing Cash Flow | 18.28 Million | -61.86 Million | 20.96 Million | -43.4 Million | -57.83 Million | -19.31 Million |
| Investments in PPE | -333 Thousand | -218 Thousand | -57 Thousand | -849 Thousand | -77 Thousand | -405 Thousand |
| Acquisitions | - | - | -21.02 Thousand | 849 Thousand | 57.75 Thousand | 18.9 Thousand |
| Investment purchases | -48.88 Million | -114.39 Million | -28.97 Million | -239.24 Million | -110.98 Million | -55.89 Million |
| Sales/Maturities of investments | 67.5 Million | 52.74 Million | 49.99 Million | 196.69 Million | 53.23 Million | 36.99 Million |
| Other Investing Activities | 18.61 Thousand | -218 Thousand | 21.02 Thousand | -849 Thousand | -57.75 Thousand | -18.9 Thousand |
| Financing Cash Flow | 816 Thousand | 125.19 Million | 680 Thousand | 85.88 Million | 31 Thousand | 85.17 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 10.95 Billion | - | -17.22 Billion | - | 8.61 Billion | 8.6 Billion |
| Common Stock Issuance | 816 Thousand | 125.19 Million | 680 Thousand | 85.88 Million | 31 Thousand | 85.17 Million |
| Other Financing Activities | 816.00 | -168 Thousand | 453 Thousand | -227 Thousand | 31 Thousand | 85.17 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.8 Million | -5.75 Million | 979 Thousand | 3.27 Million | 3.91 Million | -820 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -434 Thousand | -2.4 Million | 1 Million | 1.62 Million | -277 Thousand | -211 Thousand |
| Cash at beginning of period | 56.36 Million | 23.38 Million | 26.23 Million | 66.84 Million | 104.17 Million | 59.45 Million |
| Cash at end of period | 49.83 Million | 56.36 Million | 23.38 Million | 23.38 Million | 26.72 Million | 104.17 Million |
| Capital Expenditure | -333 Thousand | -218 Thousand | -57 Thousand | -849 Thousand | -77 Thousand | -405 Thousand |
| Effect of forex changes on cash | - | - | -17.25 Billion | -23 Thousand | 8.69 Billion | 8.55 Billion |
| Net cash flow / Change in cash | -6.52 Million | 32.97 Million | -2.85 Million | -43.45 Million | -77.44 Million | 44.71 Million |
| Free Cash Flow | -25.95 Million | -30.57 Million | -24.55 Million | -86.76 Million | -19.72 Million | -21.55 Million |
029960
DGGXF
LACTOSE
PSO
CSLI
VLHZ